GGrantIndex
Sort

261,768 grants matching gene therapy

Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations

$1,014,535
James A Decaprio · Dana-Farber Cancer Inst · R35 · FY2022 · CA

Development of humanized models using human induced pluripotent stem cells

$1,014,499
Elizabeth C Bryda · University Of Missouri-Columbia · RC2 · FY2010 · HL

Elution of a Small Molecule from a Bio Ceramic Collagen Bone Graft Device Heals Bone while InhibitingBreast Cancer Bone Metastases

$1,014,441
Bryan Samuel Margulies · Zetagen Therapeutics, Inc. · R44 · FY2021 · CA

Reprogramming of T cells for the Treatment of Melanoma

$1,014,415
Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2012 · CA

Clinical, genetic and cardiometabolic risk correlates of the gut microbiome

$1,014,404
Stanley Y Shaw · Broad Institute, Inc. · R01 · FY2017 · HL

MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm

$1,014,275
Robert C Bast · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA

Drug Development for Prostate Cancer and other Metastatic Processes

$1,014,238
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Gene Therapy for Therapeutic Angiogenesis

$1,014,190
Tissue Repair Company · R44 · FY2004 · HL

Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer

$1,014,038
Loren D Walensky · Dana-Farber Cancer Inst · R35 · FY2019 · CA

PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE

$1,014,009
Thomas Meek · Texas A&M Agrilife Research · R01 · FY2019 · AI

Isolation And Characterization Of Human Genes Affecting Chromosome Metabolism

$1,013,937
Michael A Resnick · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES

Genetic Susceptibility to Pediatric Glioma inIndividuals and Diverse populations

$1,013,932
Joseph Leo Wiemels · University Of Southern California · R01 · FY2019 · CA

Gene Therapy for Therapeutic Angiogenesis

$1,013,914
Barbara A Sosnowski · Tissue Repair Company · R44 · FY2007 · HL

Macaque and human models for preclinical development of iPSCs

$1,013,860
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Very Low Frequency EPR Imaging in Vivo Phisiology P41 EB02034

$1,013,773
Howard J Halpern · University Of Chicago · P41 · FY2011 · EB

IGF::OT::IGF - GTRP Pharmacology-Toxicology Core Lab, Task Order 6, Task Area B; FY16; CAN 8470187; AMT $1,013,722.26.

$1,013,757
Jane Maestas · Lovelace Biomedical & Environmental Research Institute · N01 · FY2016 · HL

Physicochemical Cues and Their Roles in the Angiogenic Switch

$1,013,676
Claudia Fischbach · Cornell University · U54 · FY2010 · CA

Metabolomics of subclinical and clinical cardiovascular disease

$1,013,673
Dean P. Jones · Emory University · P20 · FY2014 · HL

Oncogenic mechanisms and molecular targets in lymphoma

$1,013,664
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Oncogenic mechanisms and molecular targets in myeloma

$1,013,664
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Molecular diagnosis and outcome prediction in lymphoma

$1,013,664
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Dual-targeting allogeneic CAR T-cells for universal therapy of T-cell malignancies

$1,013,623
Sarah Marie Hein · March Biosciences Inc · R44 · FY2024 · CA

Molecular signatures for liver cancer diagnosis and treatment stratification

$1,013,528
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

The role of cancer stem cells in liver cancer heterogeneity and subtypes

$1,013,528
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Genome-Wide Discovery and Translational Research for Neural Repair

$1,013,487
Stephen M Strittmatter · Yale University · R35 · FY2024 · NS